CHRIS J. D. ZARAFONETIS, M.D.; RICHARD C. BATES, M.D.
This content is PDF only. Please click on the PDF icon to access.
It is of interest that Q fever is being encountered with increasing frequency in the United States.1, 2, 3, 4 Furthermore, it is now evident that this rickettsial infection may give rise to severe clinical disease, especially in older individuals. Indeed, at least four fatalities have been ascribed to this disorder in this country alone.5 The need for a satisfactory form of therapy is therefore apparent. In this connection, Wong and Cox have demonstrated the effectiveness of aureomycin in the disease produced experimentally.6 More recently, Lennette and his associates7 evaluated aureomycin in a clinical trial and found it to be
ZARAFONETIS CJD, BATES RC. Q FEVER: REPORT OF A CASE TREATED WITH CHLOROMYCETIN*. Ann Intern Med. 1950;32:982–987. doi: https://doi.org/10.7326/0003-4819-32-5-982
Download citation file:
Published: Ann Intern Med. 1950;32(5):982-987.
Education and Training.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use